5 completed. 5 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 5 |
| Phase 2 | 1 | Completed 1 |
Follow Post Traumatic Stress Disorder: new trials by email Literature Review of Post Traumatic Stress Disorder trials Research Report on Post Traumatic Stress Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Frontline Clinician Psilocybin Study Psilocybin (Usona Institute), Active placebo - Burnout, Caregiver, Burnout, Professional | Phase 3 | Completed | University of Washington | 30 | 2022-03-03 | 2025-03-18 |
| Burnout and Distress preventiOn With caNnabidiol in Front-line Health Care workerS deAling wIth COVID-19 Cannabidiol - Covid19, Burn Out | Phase 2 / Phase 3 | Completed | University of Sao Paulo | 120 | 2020-06-16 | 2021-09-28 |
| Brexpiprazole as Combination Therapy With Sertraline in the Treatment of Adults With Post-traumatic Stress Disorder Brexpiprazole, Sertraline, Placebo - Post Traumatic Stress Disorder | Phase 3 | Completed | Otsuka Pharmaceutical Development & Commercialization, Inc. | 591 | 2019-10-30 | 2025-05-30 |
| Brexpiprazole as Combination Therapy With Sertraline in Treatment of Adults With PTSD Brexpiprazole, Sertraline, Placebo - Post Traumatic Stress Disorder | Phase 3 | Completed | Otsuka Pharmaceutical Development & Commercialization, Inc. | 450 | 2019-10-17 | 2025-06-13 |
| Enhancing Exposure Therapy for Post Traumatic Stress Disorder (PTSD): Virtual Reality and Imaginal Exposure With a Cognitive Enhancer DCS (D-Cycloserine ) + Prolonged Imaginal Exposure, DCS (D-Cycloserine ) + Virtual Reality Exposure, Placebo + Prolonged Imaginal Exposure - Post Traumatic Stress Disorder | Phase 3 | Completed | Weill Medical College of Cornell University | 192 | 2011-05-01 | 2019-07-02 |
Stress Disorders, Post-Traumatic (5) · COVID-19 (2) · Burnout, Professional (1) · Burnout, Psychological (1) · Caregiver Burden (1) · Depression (1)
Mental Disorders (5) · Stress Disorders, Traumatic (5) · Trauma and Stressor Related Disorders (5) · Behavior (2) · Behavioral Symptoms (2) · Coronaviridae Infections (2) · Coronavirus Infections (2) · Infections (2) · Lung Diseases (2) · Nidovirales Infections (2) · Pneumonia (2) · Pneumonia, Viral (2) · RNA Virus Infections (2) · Respiratory Tract Diseases (2) · Respiratory Tract Infections (2)
Sertraline (2) · brexpiprazole (2) · Cannabidiol (1) · Cycloserine (1) · Psilocybin (1)
Otsuka Pharmaceutical Development & Commercialization, Inc. (2) · University of Sao Paulo (1) · University of Washington (1) · Weill Medical College of Cornell University (1)
United States (4) · Brazil (1)
Anthony Back, MD (1) · Barbara Rothbaum, Ph.D., ABPP (1) · JoAnn Difede, Ph.D. (1) · Jose A. Crippa, MD; PhD (1) · Skip Rizzo, Ph. D. (1)
PMID 31669451, PMID 34387679, PMID 35896533, PMID 39636638, PMID 39693081, PMID 40982703